Navigation Links
Common Hospital Infection Lengthens Patient Stays
Date:12/5/2011

MONDAY, Dec. 5 (HealthDay News) -- Hospitalized patients who are infected with Clostridium difficile -- the most common cause of infectious diarrhea in hospitals -- will lengthen their stay by about six days on average, a new study indicates.

Experts say prevention is key to controlling the spread of the bacterial infection known as C. difficile.

For the study, published Dec. 5 in the journal CMAJ, researchers analyzed information on nearly 137,000 hospital admissions in Ottawa over the course of seven years. Of those admissions, 1,393 patients became infected with C. difficile and spent 34 days in the hospital, compared with just eight day for those who did not have the infection.

However, patients with C. difficile generally had more serious illnesses, which the researchers took into account. They then calculated that becoming infected with the bacteria actually lengthened hospital stays by an average of six days.

The bacterial illness commonly occurs in older people and those with weakened immune systems. It can pass to patients from health care personnel who have touched contaminated surfaces without washing their hands, according to the U.S. Centers for Disease Control and Prevention. Beside diarrhea, symptoms include fever, nausea and loss of appetite.

About 10 percent of patients who become infected in the hospital with C. difficile will die, according to background information in a journal news release.

"We believe our study provides the most accurate measure yet of the impact of hospital-acquired C. difficile on length of hospital stay," study author Alan Forster, a senior scientist at the Ottawa Hospital Research Institute and an associate professor at the University of Ottawa, said in the release. He noted that new tools to collect hospital data and provide more accurate information are boosting infection-prevention efforts.

Study co-author Dr. David Enoch, with Peterborough and Stamford Hospitals in the United Kingdom, said in the release that prevention and oversight are essential to stopping the spread of the disease.

More information

The U.S. Centers for Disease Control and Prevention provides more information on C. difficile in health care settings.

-- Mary Elizabeth Dallas

SOURCE: CMAJ, news release, Nov. 29, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Adapting to clogged airways makes common pathogen resist powerful drugs
2. A common cholesterol drug fights cataracts, too
3. U.S. National Guard Connects Nationwide with Desktop Alert's Command and Control Mass Notification Systems and Common Alerting Protocol (CAP)
4. US21, Inc. is Granted a Wholesale Distributor Permit from the Commonwealth of Virginia Board of Pharmacy
5. New therapeutic target for most common solid cancer in childhood?
6. Migraine More Common in Women with MS
7. Contrast-enhanced MRI could play a key role in differentiating between common types of arthritis
8. Six "Common Sense" Points Not Included In The Health Care Discussion? Should They Be?
9. Six "Common Sense" Points Not Included In The Health Care Discussion? Should They Be?
10. Common osteoporosis drugs are associated with a decrease in risk of breast cancer
11. Commonwealth Leverage Group and Helium Interactive Form HIE Go-To-Market Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Common Hospital Infection Lengthens Patient Stays
(Date:8/16/2017)... Lewisville, TX (PRWEB) , ... August 16, 2017 , ... ... in the United States, named Dr. Douglas J. Harrison, as the new Medical Director ... will be the new facility Medical Director of our Sienna Plantation location,” said Dr. ...
(Date:8/16/2017)... ... , ... “God Will Break Every Chain”: an inspirational story for those shackled by the chains ... author, Evangelist Joann Shivers, a writer and a woman of great faith and wisdom. ... early age. She was born and raised in Vero Beach, Florida and has dedicated ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading ... on the 2017 Fast 50 list of Fastest Growing Companies in Tampa Bay. The ... area who has shown three consecutive years of growth. For this year’s award, Progressive ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Timothy Davis ... periodontal disease . This information can be used to develop patient-specific treatment ... The two salivary diagnostic tests, named MyPerioPath® and MyPerioID® are offered by OralDNA® ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: